K-Beauty Market Briefing — 2026-08-12

Original English analysis for global buyers. Source articles are linked; summaries are newly written, not excerpted.

regulation

The duty-free parcel era is ending in every major K-beauty market at once

A Korean industry analysis maps the global rollback of small-parcel tax exemptions: the US scrapped its USD 800 de minimis threshold in August 2025, the EU abolished its €150 exemption on 1 July 2026 with a transitional €3 flat duty per item until 2028, and Japan and the UK plan removals by 2028. Korea's direct-to-consumer beauty exports, which grew 181% over six years to KRW 1.38 trillion in H1 2026, are the channel most exposed.

Buyer takeaway: For European buyers the arithmetic now firmly favors consolidated wholesale shipments over D2C parcels, since per-item duties and customs handling erase the old cross-border price advantage — a structural argument for moving volume onto one invoice and one customs entry.

Source: Cosin Korea (Korean)

trade

BASF turns on the US tap for the sunscreen ingredient everyone was waiting for

BASF has begun supplying Tinosorb S — bemotrizinol, the newly FDA-approved broad-spectrum UV filter — to the US market, operating under an 18-month co-exclusivity alongside DSM. The company is bundling the active with formulation support, surfactants and stabilizers, effectively offering US-bound manufacturers a ready path to next-generation photostable sunscreens.

Buyer takeaway: Buyers planning US sun care assortments for 2027 should ask Korean suppliers which of their EU-proven Tinosorb S formulas are being converted for the US, because ported formulas with existing consumer track records will beat from-scratch American launches to shelf.

Source: Cosin Korea (Korean)

demand

Hugel's record half shows the aesthetics-to-cosmetics bridge is working

Hugel posted record H1 results with consolidated sales of KRW 254.5 billion, up 27.2%, as botulinum toxin sales grew 46.6% and Americas revenue more than doubled. Its cosmetics division grew 31.7% to KRW 39 billion, illustrating how Korean medical-aesthetics firms are converting clinical credibility into retail beauty lines.

Buyer takeaway: Retailers building 'derma' or post-procedure sets should look at the cosmetics lines of Korean aesthetics companies like Hugel, since clinical-brand halo supports premium pricing that pure beauty brands in the same formulas cannot command.

Source: Global Cosmetics News (Korean)

About AnD KBeauty

This briefing is researched and written by AnD KBeauty, a Seoul-based K-beauty B2B wholesale supplier for small and mid-size retailers in the US, EU/UK, the Middle East and Southeast Asia. We publish open MOQs, lead times and compliance guides with no login wall, and consolidate mixed-brand orders from 30-100 units per SKU into one shipment from Korea.

Browse the open catalog · Request a wholesale quote · All briefings